Acquired hemophilia A

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:599480D68.4
Who is this for?
Show terms as
1FDA treatments3Active trials38Specialists8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Also known as:

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Mar 2026Real-world Canadian Retrospective Study Evaluating Longitudinal Semaglutide Use on Cardio-Kidney-Metabolic Outcomes

LMC Diabetes & Endocrinology Ltd.

TrialNOT YET RECRUITING
Feb 2026Acetohydroxamic Acid Combined With a Short-Course Regimen for MDR-TB (AHA-PLUS)

Shanghai Pulmonary Hospital, Shanghai, China — PHASE2

TrialNOT YET RECRUITING
Dec 2025Beyond Observation: Validating the Ecological Relevance of the Ad-AHA Stroke Using Sensor-Based Measures

KU Leuven

TrialRECRUITING
Sep 2025The AHA Oneida Study

University of Wisconsin, Madison — NA

TrialRECRUITING
Jul 2025A Study of OBIZUR in Adults With Acquired Hemophilia A (AHA) in South Korea

Takeda

TrialRECRUITING
Aug 2024Penn Medicine Food Market Study

University of Pennsylvania — NA

TrialACTIVE NOT RECRUITING
Jun 2024Aha BOOST Arm-hand BOOST Therapy to Enhance Recovery After Stroke: Clinical, Health Economic and Process Evaluation

KU Leuven — NA

TrialRECRUITING
Jun 2024A Survey of Susoctocog Alfa (Genetical Recombination) in Participants With Acquired Haemophilia A

Takeda

TrialRECRUITING
Aug 2022Emicizumab in Patients With Acquired Hemophilia A

University of Washington — PHASE2

TrialACTIVE NOT RECRUITING
Feb 2014Exercise Testing in Peripheral Artery Disease Patients

Rennes University Hospital

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

OBIZUR

antihemophilic factor (recombinant), porcine sequence· Takeda Development Center Americas, Inc.

Treatment of bleeding episodes in adults with acquired hemophilia A

Clinical Trials

3 recruitingView all trials with filters →
Phase 21 trial
Emicizumab in Patients With Acquired Hemophilia A
Phase 2
Active
PI: Rebecca Kruse-Jarres, MD, MPH (University of Washington) · Sites: San Diego, California; Washington D.C., District of Columbia +14 more · Age: 1899 yrs
Other2 trials
A Survey of Susoctocog Alfa (Genetical Recombination) in Participants With Acquired Haemophilia A
Actively Recruiting
PI: Study Director (Takeda) · Sites: Tokyo, Tokyo
A Study of OBIZUR in Adults With Acquired Hemophilia A (AHA) in South Korea
Actively Recruiting
PI: Study Director (Takeda) · Sites: Seoul · Age: 1899 yrs

Specialists

Showing 25 of 38View all specialists →
JO
Johannes Oldenburg
Specialist
2 Acquired hemophilia A publications
RK
Robert Klamroth
Specialist
2 Acquired hemophilia A publications
PE
Patrick Ellsworth
Specialist
2 Acquired hemophilia A publications
CP
Christian Pfrepper
Specialist
2 Acquired hemophilia A publications
KA
Kagehiro Amano
Specialist
2 Acquired hemophilia A publications
MS
Midori Shima
Specialist
2 Acquired hemophilia A publications
WM
Wolfgang Miesbach
Specialist
2 Acquired hemophilia A publications
KT
Karolin Trautmann-Grill
Specialist
2 Acquired hemophilia A publications
HE
Hermann Eichler
Specialist
2 Acquired hemophilia A publications
KH
Katharina Holstein
Specialist
2 Acquired hemophilia A publications
YO
Yoshiyuki Ogawa
Specialist
2 Acquired hemophilia A publications
LM
Lei Zhang, MD
Specialist
PI on 3 active trials1 Acquired hemophilia A publication
RM
Rebecca Kruse-Jarres, MD, MPH
SEATTLE, WA
Specialist
PI on 3 active trials
AD
Andreas Tiede, Prof. Dr.
Specialist
PI on 1 active trial
XM
Xiao-Hui Zhang, MD
Specialist
PI on 16 active trials
MF
Marc Fouassier
Specialist
PI on 1 active trial
LZ
Lei Zhang
Specialist
PI on 8 active trials994 Acquired hemophilia A publications
AT
Andreas Tiede
Specialist
2 Acquired hemophilia A publications
KY
Koichiro Yoneyama
Specialist
2 Acquired hemophilia A publications
RO
Ryoto Ozaki
Specialist
2 Acquired hemophilia A publications
RK
Ryota Kobayashi
Specialist
2 Acquired hemophilia A publications
GG
George Gjerset
Specialist
PI on 1 active trial7 Acquired hemophilia A publications
JM
James J Goedert, M.D.
SILVER SPRING, MD
Specialist
PI on 1 active trial
PM
Patrick Möhnle
Specialist
2 Acquired hemophilia A publications
PK
Paul Knöbl
Specialist
2 Acquired hemophilia A publications

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources
OBIZUR(antihemophilic factor (recombinant), porcine sequence)Takeda Development Center Americas, Inc.

Travel Grants

No travel grants are currently matched to Acquired hemophilia A.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Acquired hemophilia AForum →

No community posts yet. Be the first to share your experience with Acquired hemophilia A.

Start the conversation →

Latest news about Acquired hemophilia A

Disease timeline:

New recruiting trial: The AHA Oneida Study

A new clinical trial is recruiting patients for Acquired hemophilia A

New recruiting trial: Aha BOOST Arm-hand BOOST Therapy to Enhance Recovery After Stroke: Clinical, Health Economic and Process Evaluation

A new clinical trial is recruiting patients for Acquired hemophilia A

New recruiting trial: Exercise Testing in Peripheral Artery Disease Patients

A new clinical trial is recruiting patients for Acquired hemophilia A

New recruiting trial: Beyond Observation: Validating the Ecological Relevance of the Ad-AHA Stroke Using Sensor-Based Measures

A new clinical trial is recruiting patients for Acquired hemophilia A

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Acquired hemophilia A

Are there clinical trials for Acquired hemophilia A?

Yes — 3 recruiting clinical trials are currently listed for Acquired hemophilia A on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Acquired hemophilia A?

25 specialists and care centers treating Acquired hemophilia A are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for Acquired hemophilia A?

1 patient support program are currently tracked on UniteRare for Acquired hemophilia A. See the treatments and support programs sections for copay assistance, eligibility, and contact details.